| Source publication date | |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Consumer health outlet |
| Population | Women |
| Source | DeepDyve Blog |
| URL | blog.deepdyve.com/2026/10/30/menopause-hormone-therapy-research-roundup (opens in a new tab) |
Specific claim evaluated
A 2026 narrative review describes testosterone as the most abundant biologically active sex steroid in women, with roles in several organ systems, while noting that strength of evidence varies by system and that measurement needs standardization.
Primary research supporting or contradicting the claim
Randomized evidence supports benefit for sexual function in postmenopausal women but shows no effects on body composition, musculoskeletal or cognitive outcomes (Islam et al., 2019); direct assays are unreliable in the female range (Davis et al., 2019).
Corrected evidence-based interpretation
Accurate. Physiological roles of testosterone in women do not establish therapeutic benefit outside hypoactive sexual desire disorder.
Rationale for grade
The summary reports the review's own caveats about variable evidence strength and assay standardization. It does not translate physiological roles into treatment claims. The roundup format attributes findings to their sources.
References
- Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. PMID
Supporting excerpt: "The only evidence-based indication for testosterone for women is for HSDD." - Islam RM, Bell RJ, Green S, Page MJ, Davis SR. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019;7(10):754-766. PMID
Supporting excerpt: "Testosterone is effective for postmenopausal women with low sexual desire causing distress"